跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,250 条关于
“MACE”
全部
6,250
临床试验
5,681
药物
133
机构
23
资讯
413
去年
MACE Endpoint Faces Scrutiny in Cardiovascular Trials
上个月
Novo Nordisk's Ziltivekimab Fails Phase 3 ZEUS Trial, Missing Primary MACE Endpoint in Cardiovascular Disease
去年
GLP-1 Receptor Agonists Show Lower Risk for MACE and VTE in Lupus and Type 2 Diabetes Patients Compared to DPP4 Inhibitors
去年
Obicetrapib Shows Promise in Phase 3 BROADWAY Trial, Reduces LDL-C and MACE
去年
FDA Expands Trulicity Label to Include Cardiovascular Risk Reduction in Type 2 Diabetes
2年前
Prucalopride Shows Favorable Safety Profile in Chronic Idiopathic Constipation Treatment
去年
FDA Expands Repatha Indication to Include Adults at High Risk for Cardiovascular Events Without Prior Disease Diagnosis
去年
AI Study Suggests Millions More Could Benefit from GLP-1 Heart Benefits
2年前
OCT-Guided PCI Improves Outcomes in Complex Coronary Lesions: OCCUPI Trial
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
第 1 页,共 42 页
上一页
下一页